February 21, 2022


It's Showtime! WCN'22 Raising-the-Curtain Sessions Launch Today!

Welcome to the start of an invigorating week of science, education, and networking at the World Congress of Nephrology 2022.
February 21-27, the week ahead at a glance:
Monday: ISN Raising-the-Curtain sessions
Tuesday: ISN Raising-the-Curtain sessions
Wednesday: The Professor Donal O’Donoghue, Global Kidney Policy Forum
Thursday: Pre-congress courses
Friday-Sunday: World Congress of Nephrology 2022 Scientific Program
Registration for the congress remains available throughout the event.
Except for the pre-congress courses, these sessions are included with full-congress registration or register for free via the “Open-Access Sessions” on the WCN Portal to attend a particular session.
The ISN World Congress of Nephrology, Kuala Lumpur, Malaysia, 24/02/2022-27/02/2022, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 18 European CME credits (ECMEC®s).
Find out more here.

Discover the WCN'22 Poster Abstracts in Kidney International Reports

The World Congress of Nephrology 2022 accepted abstracts have been published in the latest supplement to Kidney International Reports.
Read WCN'22 open-access abstracts here.

Did You Catch the February Pre-Congress Newsletter?

The February edition of the pre-congress newsletter features a sneak preview of WCN'22 content from prominent guest speakers:
  • Brenda Hemmelgarn on shared decision-making to treat chronic kidney disease
  • Lydia Kamaruzaman on improving kidney function testing 
  • Frances Mortimer on sustainable kidney care
  • Kar Hui Ng on the genetic causes of kidney disease in Asia 
  • Katalin Susztak on genetic markers for inflammation and fibrosis in kidney disease 
  • Esther Tan on setting up urgent-start peritoneal dialysis programs 
The newsletter also guides you on maximizing WCN’22 platform features and includes updates on industry symposia, social media, advocacy, and young nephrologist activities during the congress.

A Few Days Left to Pick a Winner: Watch and Vote for the Finalists in the ISN Community Film Event Before February 26

Watch the shortlisted films and cast your vote!
The seven films competing for the 2022 ISN Community Best Film award present unsung heroes - all winners for overcoming difficult circumstances and helping raise awareness of kidney health issues.
Which of these seven films will be honored as the overall winner? Your vote helps decide the outcome!
Discover these stories now:
  • A new lease of life after a kidney transplant
  • Living well with chronic kidney disease - pregnancy in dialysis
  • Overcoming isolation for those living with Alport Syndrome
  • Nocturnal hemodialysis in a home-training center
  • Altruistic kidney transplants in Israel
  • Daily struggles for patients in Honduras with kidney deficiency
  • The harrowing wait for a kidney donation
The deadline to cast your vote is February 26, 2022, at midnight MYT. The winner will be announced and awarded during the ISN World Congress of Nephrology 2022.

Young Nephrologists

By Siah Kim (Australia), Member, Young Nephrologists Committee

Drum Roll, Please! ISN Young Nephrologists On-Stage at WCN'22

WCN'22 is just around the corner, and the Young Nephrologists Committee is thrilled to invite all young nephrologists (and the young at heart!) to a program packed with exciting events planned with you in mind.
On Friday, February 25 at 18:00 MYT, we kick off the Young Nephrologists session, “The Future is Bright: Young Nephrologists in Action,” in Room 4.
This is the moment to cast off the gloominess of the past two years and get inspired by stories from young nephrologists who have maintained their commitment to education, training, and patient care, despite being in the thick of the pandemic.



Deadline Extension: More Time to Get Involved in the ISN Frontiers Meeting in Bergamo, Italy - Submit Your Abstract Until March 2

The new deadline for abstract submissions and travel grant applications is March 2, 2022. Submit your abstract here.
Take advantage of a rare opportunity to present your research work to clinicians, scientists, academics, and general practitioners from around the world at the ISN Frontiers Meeting ‘Complement-related kidney diseases: classification, genetics, and treatment.'
This meeting is accredited by the European Accreditation Council for Continuing Medical Education - full details here.
Accepted abstracts will be presented as posters and published in Kidney International Reports. Some abstracts will be selected for oral presentations at the meeting.

Supported by                  



Announcing Three New ISN-TTS Sister Transplant Centers Partnerships and One Graduating Pair

The ISN and The Transplantation Society (TTS) are pleased to announce the results from the latest round of applications to the ISN-TTS Sister Transplant Centers Program.
Six centers will work in pairs over the next few years toward creating new kidney transplant centers and developing existing kidney transplant programs in the emerging health centers:
  • Mittaphab Hospital, Laos and Ramathibodi Excellent Center for Organ Transplantation, Thailand
  • Universiti Teknologi MARA, Malaysia and Singapore General Hospital-Health Sciences Authority, Singapore
  • Hôpital Universitaire de Mirebalais, Haiti and Beth Israel Deaconess Medical Center, USA
Explore the map of all active ISN-TTS Sister Transplant Centers partnerships here.

Submit a Proposal to the ISN Clinical Research Program

Could your region benefit from support for research and education initiatives that help detect and manage non-communicable chronic diseases such as CKD, AKI, hypertension, diabetes, and cardiovascular disease? The ISN Clinical Research Program helps implement such projects.
Proposals for the ISN Clinical Research Program should be submitted to an ISN Regional Coordinator for review before April 1, 2022.
Once approved, proposals can be submitted here until May 1, 2022.

Help Advance Kidney Care in Your Region: Apply for an Interventional Nephrology Scholarship

The ISN is currently inviting applications for ISN Interventional Nephrology Scholarships.
The deadline to apply is April 1, 2022. Start your application here.
These short courses offer training in interventional nephrology procedures to ISN members from low- and middle-income countries.
Two training options are available - Foundation (Level 1) and Advanced (Level 2):
  • Foundation courses comprise two to four weeks of observational and hands-on training in a specific procedure.
  • Advanced courses include three months of hands-on training in a broad spectrum of procedures, notably endovascular.



Read the World Kidney Day Scientific Editorial in Kidney International

The World Kidney Day (WKD) Steering Committee submits an annual scientific editorial to a range of medical journals as part of WKD efforts to increase kidney disease awareness.
Read this year's editorial, “Kidney health for all: bridging the gap in kidney health education and literacy,” in Kidney International here.
Find a summary of the article on the World Kidney Day website.
The authors encourage kidney organizations to work to shift responsibility for patient health literacy away from patients and toward health care providers and policymakers.

Take Part in the WKD #ShowYourKidneys Social Media Challenge

The World Kidney Day (WKD) online challenge #ShowYourKidneys is a fun way to highlight where the kidneys are in the body and what they do.
It's easy to take part!
  • Take a picture of yourself - front or back view - using your fists to indicate the location of your kidneys.
  • Add a special kidney-themed frame to your photo: Download here.
  • Share the photo on social media using the hashtag #ShowYourKidneys.
  • Find additional inspiration for your social media post here.
World Kidney Day social media platforms will share all photos tagged @worldkidneyday.
The ISN encourages all to participate in this initiative and share it with their colleagues, patients, and families. Discover and use all WKD resources here.

Promoting Global Kidney Health at the WHO 150th Session of the Executive Board

The ISN submitted three statements supporting global kidney health, as a co- and sole-signatory, at the 150th session of the World Health Organization’s Executive Board, held virtually, 24-29 January 2022.
The ISN was the sole signatory of “Draft recommendations on how to strengthen the design and implementation of policies, including those for resilient health systems and health services and infrastructure, to treat people living with noncommunicable diseases (NCDs) and to prevent and control their risk factors in humanitarian emergencies,” advising member states to:
  • Integrate essential medication and diagnostics for kidney disease into existing NCD emergency plans
  • Increase investment in such plans to ensure access to high-quality, essential services for people living with kidney disease in humanitarian emergencies



Newly Revised ISN-ACT Clinical Trials Toolkit Available to Explore Now

Explore the second revised edition of the ISN-ACT Clinical Trials Toolkit here.
The online Clinical Trials Toolkit was first launched in 2020 to provide the kidney community with a central and user-friendly resource for those wishing to participate in randomized research.
Watch a short introductory video on the toolkit here.
Listen to a podcast on the toolkit here (episode 7, part 2).
The toolkit is a hub for researchers, providing essential evidence to guide care for kidney disease patients. It assists anyone wishing to start a clinical trial or participate as a trial site, regardless of their level of experience.
Watch a webinar on the toolkit presented by David Wheeler, Brendan Smyth, Rasha Hussein, and Augusto Cesar Soares dos Santos Jr. here.


Upcoming Webinars

Thursday, March 10

World Kidney Day 2022:
Bridge the Knowledge Gap to Better Kidney Care - Bringing Together the Community for Kidney Health

Session 1: 11 a.m. CET / Session 2: 10 p.m. CET
Speakers: Agnes Fogo, USA
SF Lui, Hong Kong
Verónica Martínez, Mexico
Manvir Victor, Malaysia
Ann Bonner, Australia
Beatrice Titilola Segun-Agboola, Nigeria
Paul Laffin, France
Moderators: Robyn Langham, Australia (Session 1)
Kam Kalantar Zadeh, USA (Session 2)
Monday, March 14, 4 p.m. CET

Joint Webinar on the CKD Early Identification and Intervention Toolkit

Speakers: Vivekanand Jha, India
Ana Cebrian, Spain
Domingo Orozco-Beltran, Spain
Moderator: Magdalena Madero, Mexico
This webinar is supported by an unrestricted educational grant from AstraZeneca.

Recorded Webinar

Grand Rounds in Pediatric Nephrology:
An ISN-IPNA Sister Centers initiative - Approach to Infantile Hypercalcemia




Kidney International on COVID-19


Kidney International Editorial Selections


The Changing Role of Glucocorticoids in the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (AAV)

This editorial outlines the use of Glucocorticoids (GCs) to treat patients with antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV).
The authors discuss recent randomized control trials on AAV management that may limit GC exposure; uncontrolled studies that demonstrate the potential of using a regimen combining cyclophosphamide and rituximab, and present findings from the Prolonged REmission-MAINtenance therapy in systemic vasculitis (REMAIN) study. The authors propose considerations for future studies based on this analysis. The Lupus Nephritis Management Renaissance

The Lupus Nephritis Management Renaissance

This review examines the overall strategy of managing Lupus Nephritis (LN) as new therapies come into use. It assesses the use of kidney biopsies, molecular technologies, and LN Biomarkers and considers how best to use these developments now and in the future.

GLP-1 Receptor Agonist Versus DPP4 Inhibitor and Kidney and Cardiovascular Outcomes in Clinical Practice in Type-2 Diabetes

A cohort study compares kidney and cardiovascular outcomes in individuals who started GLP1-RA or dipeptidyl peptidase-4 inhibitors (DPP4i) to help clarify whether glucagon-like peptide-1 receptor agonists (GLP1-RA) reduce detrimental kidney outcomes. The use of GLP1-RA was associated with a lower risk of kidney outcomes compared with DPP4i. Reductions in both kidney outcomes and MACE were similar in magnitude to those reported in large cardiovascular outcome trials.

Kidney International Reports Editorial Selection


Nephrology Workforce and Education in Conflict Zones

Using data collected initially to establish a conservative kidney management program in Northwestern Syria, the authors of this editorial examine the degree of nephrologist shortages in conflict zones and the effects of conflict on nephrology training.
They propose possible solutions to alleviate the consequences of a lack of appropriate training due to warfare, acknowledging that in areas of protracted conflict, nephrology training programs need the support of local volunteers and international humanitarian forces to be beneficial.